See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Eli Lilly and Company (LLY) - free report >>
Take-Two Interactive Software, Inc. (TTWO) - free report >>
Electromed, Inc. (ELMD) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eli Lilly and Company (LLY) - free report >>
Take-Two Interactive Software, Inc. (TTWO) - free report >>
Electromed, Inc. (ELMD) - free report >>
Image: Shutterstock
New Strong Sell Stocks for May 13th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
CarParts.com, Inc. (PRTS - Free Report) operates as an online provider of aftermarket auto parts and accessories. The Zacks Consensus Estimate for its current year earnings has been revised 43.8% downward over the last 30 days.
Take-Two Interactive Software, Inc. (TTWO - Free Report) develops, publishes, and markets interactive entertainment solutions. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 30 days.
Electromed, Inc. (ELMD - Free Report) develops, manufactures, markets, and sells airway clearance therapy and related products. The Zacks Consensus Estimate for its current year earnings has been revised 8.8% downward over the last 30 days.
Eli Lilly and Company (LLY - Free Report) discovers, develops, manufactures, and markets human pharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised 2.2% downward over the last 30 days.
Colliers International Group Inc. (CIGI - Free Report) provides commercial real estate services to corporate and institutional clients. The Zacks Consensus Estimate for its current year earnings has been revised 3.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.